{"disease":{"id":"undisclosed-indication-phase-1-terminated","name":"undisclosed indication phase 1 terminated"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-07899895","indication_name":"Undisclosed indication (Phase 1 terminated)","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07899895","generic_name":"pf-07899895","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Not disclosed","drug_class":"Unknown","quality_score":null,"revenue":null,"mechanism":"Mechanism of action not disclosed; Phase 1 study terminated before pharmacological characterization."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}